| scholarly article | Q13442814 |
| P50 | author | Roger Preston | Q58710900 |
| James T B Crawley | Q74754349 | ||
| P2093 | author name string | David A Lane | |
| Jonathan K Lam | |||
| Sara Zanardelli | |||
| Chan K N Chan Kwo Chion | |||
| P2860 | cites work | Biochemistry and genetics of von Willebrand factor | Q22003890 |
| Binding of ADAMTS13 to von Willebrand factor | Q24299876 | ||
| ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor | Q24303587 | ||
| ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions | Q33344837 | ||
| VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13 | Q33356956 | ||
| Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate | Q33357898 | ||
| FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay | Q33365643 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| Biosynthesis, processing and secretion of von Willebrand factor: biological implications | Q34423458 | ||
| The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor. | Q36959300 | ||
| Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. | Q36986074 | ||
| Role of chloride ions in modulation of the interaction between von Willebrand factor and ADAMTS-13. | Q40439049 | ||
| Type 2 A (group II) von Willebrand disease mutations increase the susceptibility of VWF to ADAMTS-13. | Q45154444 | ||
| Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. | Q51610600 | ||
| Localization of binding sites within human von Willebrand factor for monomeric type III collagen | Q68816542 | ||
| Lipid-protein interactions in blood coagulation | Q77521448 | ||
| Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations | Q80477437 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1555-1563 | |
| P577 | publication date | 2005-10-12 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | ADAMTS13 substrate recognition of von Willebrand factor A2 domain | |
| P478 | volume | 281 |
| Q33820902 | A model for single-substrate trimolecular enzymatic kinetics. |
| Q33567628 | A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor. |
| Q36109433 | A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. |
| Q33393728 | A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura |
| Q38859075 | ADAMTS-13 glycans and conformation-dependent activity. |
| Q29568910 | Allosteric activation of ADAMTS13 by von Willebrand factor. |
| Q33387616 | An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF |
| Q37903936 | Biology and physics of von Willebrand factor concatamers |
| Q27670774 | Calcium modulates force sensing by the von Willebrand factor A2 domain |
| Q35165568 | Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor. |
| Q33419359 | Conformational activation of ADAMTS13. |
| Q41946735 | Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity |
| Q92797831 | Crystal structure and substrate-induced activation of ADAMTS13 |
| Q37428907 | Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor |
| Q33393227 | Escherichia coli-derived von Willebrand factor-A2 domain fluorescence/Förster resonance energy transfer proteins that quantify ADAMTS13 activity |
| Q35193294 | Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease |
| Q92266460 | Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis |
| Q36843699 | Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity |
| Q33278139 | Further characterization of ADAMTS-13 inactivation by thrombin |
| Q37317725 | Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site |
| Q35690203 | Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13. |
| Q35105077 | Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13). |
| Q42397144 | Mechanistic studies on ADAMTS13 catalysis |
| Q42013734 | Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor |
| Q39299024 | N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor. |
| Q42581851 | Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation |
| Q38145381 | Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease |
| Q33377517 | Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura |
| Q36137447 | Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases |
| Q33395978 | Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain |
| Q42404760 | Shear tango: dance of the ADAMTS13/VWF complex |
| Q30364288 | Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers. |
| Q27655615 | Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor |
| Q39677665 | The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity. |
| Q40220379 | The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting |
| Q34107517 | The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function |
| Q35197446 | The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis. |
| Q37602563 | Translational medicine advances in von Willebrand disease |
| Q33795688 | Unfolding the A2 domain of von Willebrand factor with the optical trap |
| Q34196324 | Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. |
| Q55332935 | Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W. |
| Q34106824 | von Willebrand factor, Jedi knight of the bloodstream |
Search more.